UW Medicine's “second generation” COVID-19 vaccine is nearing the end of clinical testing, and may soon be administered in South Korea. FOX13
is nearing the end of clinical testing, and may soon be administered in South Korea.
Meanwhile, the South Korea-based company leading the vaccine's clinical development, SK bioscience, is seeking authorization for use there.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
White House: Without funding US will lose COVID treatmentsAfter two years at the front of the line for COVID-19 vaccines and treatments, the U.S. could soon have to begin taking a number.
Lire la suite »
Their mom died of COVID. They say conspiracy theories are what really killed herAs America approaches a million deaths from COVID-19, many thousands of families have been left wondering whether available treatments and vaccines could have saved their loved ones.
Lire la suite »
Study: Longer Vaccine Interval May Boost Antibodies 9 TimesA longer interval between the two primary COVID-19 vaccine doses can generate up to nine times as many antibodies, new research says.
Lire la suite »
COVID shots still work but researchers hunt new improvementsCOVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster
Lire la suite »
COVID Shots Still Work But Researchers Hunt New ImprovementsCOVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster
Lire la suite »
COVID shots still work but researchers hunt new improvementsCOVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster.
Lire la suite »